Molecular Diagnostics Devices And Equipment Market Trends And Growth Drivers Point To Strong Future Potential
Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
The molecular diagnostics devices and equipment market has witnessed significant expansion recently, driven by advances in technology and rising demand for precise medical testing. As diagnostics become more integral to personalized healthcare and disease management, the market is set to continue its robust growth trajectory. The following analysis delves into the market’s current size, growth drivers, segmentation, major players, and regional outlook.
Molecular Diagnostics Devices and Equipment Market Size and Projected Growth
In recent years, the molecular diagnostics devices and equipment market has experienced rapid growth. It is projected to increase from $27.23 billion in 2025 to $30.33 billion in 2026, representing a compound annual growth rate (CAGR) of 11.4%. This expansion during the historical period is largely attributed to the rise in infectious disease testing, broader genetic screening initiatives, increased use of molecular diagnostics in cancer care, enhanced sequencing accuracy, and greater clinical recognition of molecular testing’s value.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2595&type=smp
Looking ahead, the market is expected to accelerate, reaching $48.84 billion by 2030 with a CAGR of 12.7%. The forecast period’s growth factors include rising demand for personalized medicine, increased investments in genomic diagnostics, growth of decentralized molecular testing, wider adoption of automated sample processing technologies, and a stronger focus on early detection of diseases. Key trends shaping this future growth include expanded use of PCR-based testing, next-generation sequencing technologies, integrated diagnostic software and bioinformatics, companion diagnostics, and the push for early and individualized diagnosis.
Rising Infectious Disease Cases Fueling Molecular Diagnostics Market Expansion
One of the primary forces propelling growth in the molecular diagnostics devices and equipment market is the increasing prevalence of infectious diseases. These illnesses, caused by bacteria, viruses, fungi, or parasites, can spread from person to person or between animals and humans. Factors such as antimicrobial resistance, globalization and travel, urbanization, socioeconomic inequalities, and an aging population are contributing to the rise in infectious diseases worldwide.
Access The Complete Molecular Diagnostics Devices And Equipment Market Report:
Molecular diagnostic tools play a crucial role in identifying and managing such infections. For example, data from the US Centers for Disease Control and Prevention shows that tuberculosis cases increased from 8,320 in 2022 to 9,615 in 2023, with the incidence rate rising from 2.5 to 2.9 per 100,000 individuals. This growing burden of infectious diseases directly supports expanded demand for molecular diagnostic devices and equipment.
Breakdown of Molecular Diagnostics Devices and Equipment Market by Segment
The molecular diagnostics devices and equipment market is segmented based on various categories:
1) Product type including instruments, reagents and consumables, and software
2) Technology such as DNA sequencing, polymerase chain reaction (PCR), isothermal nucleic acid amplification technology, transcription mediated amplification (TMA), in situ hybridization, microarrays, mass spectrometry, and others
3) Application areas including cancer, pharmacogenomics, genetic testing, infectious diseases, prenatal diagnostics, and other uses
4) End users comprising diagnostic laboratories, hospitals, and other groups
Further subcategories include specific instruments like PCR machines, nucleic acid analyzers, DNA sequencers, and microarrays. Reagents and consumables cover PCR reagents, DNA probes and primers, sample preparation kits, and control materials. Software segments include data analysis programs, laboratory information management systems (LIMS), bioinformatics software, and integration software for instrumentation.
Innovations and Trends Shaping Future Prospects in Molecular Diagnostics
Leading companies in the molecular diagnostics field are innovating by developing high-throughput sample-to-result instruments that improve efficiency and versatility. These systems build on proven extraction and assay technologies, allowing continuous loading of samples and reagents with real random-access operations. Users can run multiple PCR reagents, protocols, and sample types simultaneously, enhancing flexibility.
For instance, in April 2023, ELITechGroup, a France-based in-vitro diagnostics company, launched such a high-throughput molecular diagnostics instrument. This product aims to streamline workflows and boost diagnostic capabilities, reflecting the broader industry trend of enhancing automation and scalability.
Top Players Competing in the Molecular Diagnostics Devices and Equipment Market
Several prominent companies are key players in this market, including F. Hoffmann-La Roche Ltd, QIAGEN N.V., Abbott Laboratories, Danaher Corporation, Biomérieux, Becton Dickinson & Co, Siemens Healthineers AG, Grifols S.A., Sysmex Corporation, Abbott India Limited, Qiagen India Pvt Ltd, Biocartis, Bio-Techne India Private Limited, Cleaver Scientific, Zhejiang Di’an Diagnostics Technology Co. Ltd, Kindstar Global, BGI-Shenzhen, OriGene Technologies, Nippon Becton Dickinson Company, QuantuMDx, Yourgene Health, Genefirst, TestLine, Hologic Inc., Illumina Inc., Cepheid Inc., Agilent Technologies Inc., AutoGenomics, Bio-Rad Laboratories Inc, Ortho Clinical Diagnostics Inc, Sysmex Middle East FZ-LLC, and QIAGEN SA (Pty) Ltd. These companies lead innovation and competition through product development, strategic partnerships, and global reach.
Regional Analysis Reveals Asia-Pacific as a Key Market for Molecular Diagnostics
In 2025, Asia-Pacific was the largest market for molecular diagnostics devices and equipment worldwide. This region is also expected to register the fastest growth during the forecast period, driven by increasing healthcare investments, expanding diagnostic infrastructure, and a rising patient population. Other key geographic markets include South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, each contributing to the global outlook with varied growth dynamics and opportunities.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
